Costs and outcomes of PAPNET secondary screening technology for cervical cytologie evaluation a community hospital's experience

Archives of Family Medicine

Volumn 8, Issue 1, 1999, Pages 52-55

  Brotzman, Gregory L ^a  

^a Coltimbifl Family Care Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMMUNITY HOSPITAL; ECONOMICS; FEMALE; HUMAN; MASS SCREENING; METHODOLOGY; NOTE; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HOSPITALS, COMMUNITY; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0032601693     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.8.1.52     Document Type: Article

References (1)

1. Kurman RJ, Henson DE, Herbst AL, Moller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology: the 1992 National Cancer Institute Workshop. JAMA. 1994;271:1866-1869.